Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.

The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...

Treating older people with diabetes is challenging due to multiple medical comorbidities that might interfere with patients' ...

Digital health company Liva Healthcare has acquired UK-based Momenta, a provider of digital, virtual, and in-person healthy ...

US-based pharmaceutical company Eli Lilly is planning to launch Mounjaro, an anti-diabetes and weight loss drug in India by 2025 after regulatory approvals, reported News18 citing officials from ...

At the 2024 SEMA Show, Meguiar's introduced a dozen new products, including a waterless wash/wax product, two odor-fighting sprays and a heavy-duty trim restoration kit. The company also launched ...

Tirzepatide, the active ingredient in Eli Lilly's diabetes drug Mounjaro, may be an effective alternative to painful daily treatment for a rare disorder, according to research published Jan. 29 in ...

Meanwhile, Lilly also confirmed that it will start running a head-to-head cardiovascular outcomes trial for Trulicity and one of its pipeline diabetes candidates – dual GIP/GLP1 agonist ...

We took advantage of price dislocations in several leading growth franchises to enhance our health care and consumer discretionary ... to portfolio holding Eli Lilly (LLY) due to delays in scaling ...

CHARLOTTE — The Charlotte Hornets filled the Spectrum Center lobby, assembling 3,000 care kits for U.S. service members Tuesday. It’s an event the organization has held for 11 years.

With its offering of tirzepatide (branded as Mounjaro and Zepbound), Eli Lilly and Co. (NYSE: LLY) was another key pharma player in this new type of treatment for diabetes and obesity.